Palisade Bio
Stock Forecast, Prediction & Price Target
Palisade Bio Financial Estimates
Palisade Bio Revenue Estimates
Palisade Bio EBITDA Estimates
Palisade Bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $250K 0% | Avg: $12.14M Low: $12.14M High: $12.14M avg. 4759.2% | Avg: $27.87M Low: $27.87M High: $27.87M avg. 129.42% | Avg: $47.71M Low: $47.71M High: $47.71M avg. 71.18% | Avg: $48.22K Low: $48.22K High: $48.22K avg. -99.89% |
Net Income
% change YoY
| $-27.27M N/A | $-12.79M 53.06% | $-12.3M 3.89% | Avg: $-19.84M Low: $-6.42M High: $-1.61M avg. -61.36% | Avg: $-23.62M Low: $-7.32M High: $-1.47M avg. -19.03% | Avg: $-5.11M Low: $-5.11M High: $-5.11M avg. 78.35% | Avg: $-11.02M Low: $-11.02M High: $-11.02M avg. -115.51% |
EBITDA
% change YoY
| $-44.28M N/A | $-15.15M 65.78% | $-12.28M 18.93% | Avg: $-2.42M Low: $-2.42M High: $-2.42M avg. 80.21% | Avg: $-5.57M Low: $-5.57M High: $-5.57M avg. -129.42% | Avg: $-9.54M Low: $-9.54M High: $-9.54M avg. -71.18% | Avg: $-9.64K Low: $-9.64K High: $-9.64K avg. 99.89% |
EPS
% change YoY
| -$146.46 N/A | -$14.54 90.07% | -$27.01 -85.76% | Avg: -$8.81 Low: -$14.08 High: -$3.54 avg. 67.38% | Avg: -$9.65 Low: -$16.07 High: -$3.23 avg. -9.53% | Avg: -$11.22 Low: -$11.22 High: -$11.22 avg. -16.21% | Avg: -$24.17 Low: -$24.17 High: -$24.17 avg. -115.51% |
Operating Expenses
% change YoY
| $41.85M N/A | $15.31M -63.41% | $13.32M -13.00% | Avg: $1.87B Low: $1.87B High: $1.87B avg. 14013.63% | Avg: $4.31B Low: $4.31B High: $4.31B avg. 129.42% | Avg: $7.38B Low: $7.38B High: $7.38B avg. 71.18% | Avg: $7.46M Low: $7.46M High: $7.46M avg. -99.89% |
FAQ
What is Palisade Bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -29.38% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -6.42M, average is -19.84M and high is -1.61M.
What is Palisade Bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1214.97% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $12.14M, average is $12.14M and high is $12.14M.
What is Palisade Bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -18.47% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$14.08, average is -$8.81 and high is $-3.54.
What is the best performing analyst?
In the last twelve months analysts have been covering Palisade Bio stock. The most successful analyst is Naz Rahman whose win rate is 100%. He has correctly predicted 1/1 price targets.